These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10543284)
1. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. Echazarreta AL; Gómez FP; Ribas J; Achaval M; Barberà JA; Roca J; Chung KF; Rodriguez-Roisin R Eur Respir J; 1999 Sep; 14(3):616-21. PubMed ID: 10543284 [TBL] [Abstract][Full Text] [Related]
2. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. Gómez FP; Roca J; Barberà JA; Chung KF; Peinado VI; Rodriguez-Roisin R Eur Respir J; 1998 Apr; 11(4):835-9. PubMed ID: 9623685 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768 [TBL] [Abstract][Full Text] [Related]
7. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. Gómez FP; Iglesia R; Roca J; Barberà JA; Chung KF; Rodriguez-Roisin R Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1559-64. PubMed ID: 9603138 [TBL] [Abstract][Full Text] [Related]
8. Lack of systemic oxidative stress during PAF challenge in mild asthma. Echazarreta AL; Rahman I; Peinado V; Barberà JA; Roca J; MacNee W; Rodríguez-Roisin R Respir Med; 2005 May; 99(5):519-23. PubMed ID: 15823446 [TBL] [Abstract][Full Text] [Related]
9. Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study. Gómez FP; Marrades RM; Iglesia R; Roca J; Barberà JA; Chung KF; Rodriguez-Roisin RM Eur Respir J; 1999 Sep; 14(3):622-6. PubMed ID: 10543285 [TBL] [Abstract][Full Text] [Related]
10. Salbutamol inhibits pulmonary effects of platelet activating factor in man. Roca J; Félez MA; Chung KF; Barberà JA; Rotger M; Santos C; Rodriguez-Roisin R Am J Respir Crit Care Med; 1995 Jun; 151(6):1740-4. PubMed ID: 7767515 [TBL] [Abstract][Full Text] [Related]
11. Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics. Moscato G; Dellabianca A; Falagiani P; Mistrello G; Rossi G; Rampulla C Am Rev Respir Dis; 1991 Mar; 143(3):561-6. PubMed ID: 2001067 [TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects. Foresi A; Pelucchi A; Mastropasqua B; Cavigioli G; Carlesi RM; Marazzini L Am Rev Respir Dis; 1992 Aug; 146(2):364-8. PubMed ID: 1489126 [TBL] [Abstract][Full Text] [Related]
13. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Spring J; Johnston SR; Seale J; Ind PW Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250 [TBL] [Abstract][Full Text] [Related]
14. Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects. Louis R; Bury T; Corhay JL; Radermecker MF Chest; 1994 Oct; 106(4):1094-9. PubMed ID: 7924479 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium. Hayes JP; Chung KF; Barnes PJ Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735 [TBL] [Abstract][Full Text] [Related]
16. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics. Louis R; Bury T; Corhay JL; Radermecker M Chest; 1993 Sep; 104(3):806-10. PubMed ID: 8365293 [TBL] [Abstract][Full Text] [Related]
17. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. Taylor IK; Ward PS; Taylor GW; Dollery CT; Fuller RW J Appl Physiol (1985); 1991 Oct; 71(4):1396-402. PubMed ID: 1661723 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219. Kidney JC; Ridge SM; Chung KF; Barnes PJ Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421 [TBL] [Abstract][Full Text] [Related]
19. Inhaled furosemide prevents ultrasonically nebulized water bronchoconstriction in children with both atopic and nonatopic asthma. Shimizu T; Mochizuki H; Morikawa A; Kuroume T Chest; 1993 Dec; 104(6):1723-6. PubMed ID: 8252951 [TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma. Rajakulasingam K; Polosa R; Church MK; Howarth PH; Holgate ST Thorax; 1994 May; 49(5):485-91. PubMed ID: 8016771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]